We previously demonstrated that glucose transporter inhibition by the hepatic GLUT inhibitor, trehalose, enhances peripheral thermogenesis, and mitigates hepatic steatosis by inducing hepatocyte fasting-like pathways24,26,29. Here, SLC2A1 is linked to fatty liver disease.